⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL116202 | 0.71 | — | — | |
| SCHEMBL948179 | 0.67 | — | — | |
| SCHEMBL6244987 | 0.67 | — | — | |
| SCHEMBL66165 | 0.67 | — | — | |
| SCHEMBL9068419 | 0.67 | — | — | |
| SCHEMBL39039 | 0.67 | — | — | |
| SCHEMBL342085 | 0.67 | — | — | |
| SCHEMBL375023 | 0.65 | — | — | |
| SCHEMBL712469 | 0.65 | — | — | |
| SCHEMBL11659736 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12036319-B2 | Polyvalent sting activating compositions and uses thereof | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-07-16 | — | — | US | disclosed |
| WO-2024112397-A1 | COMBINATION THERAPIES COMPRISING KRAS INHIBITORS AND SPH2 INHIBITORS | HUYABIO INTERNATIONAL, LLC (US) | 2024-05-30 | — | — | WO | disclosed |
| CN-118056309-A | Flame-retardant nonaqueous electrolyte and secondary battery using same | 国立大学法人京都大学 | 2024-05-17 | — | — | CN | disclosed |
| US-20240141084-A1 | BIOFOULING RESISTANT COATINGS AND METHODS OF MAKING AND USING THE SAME | SILQ TECHNOLOGIES CORPORATION | 2024-05-02 | — | — | US | disclosed |
| US-11964971-B2 | Methods and compositions for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2024-04-23 | — | — | US | disclosed |
| EP-4333850-A1 | SHP2 INHIBITOR MONOTHERAPY AND USES THEREOF | Huyabio International, LLC (US) | 2024-03-13 | — | — | EP | disclosed |
| EP-4334317-A1 | COMBINATION THERAPIES COMPRISING SHP2 INHIBITORS AND EGFR TYROSINE KINASE INHIBITORS | Huyabio International, LLC (US) | 2024-03-13 | — | — | EP | disclosed |
| EP-4334318-A1 | COMBINATION THERAPIES COMPRISING SHP2 INHIBITORS AND PD-1 INHIBITORS | Huyabio International, LLC (US) | 2024-03-13 | — | — | EP | disclosed |
| CN-117677619-A | Combination therapy comprising an SHP2 inhibitor and a PD-1 inhibitor | 沪亚生物国际有限责任公司 | 2024-03-08 | — | — | CN | disclosed |
| EP-3568390-B1 | SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST (US) | 2024-03-06 | — | — | EP | disclosed |
| EP-1375472-A1 | BENZENE COMPOUND AND SALT THEREOF | Eisai Co., Ltd. (JP) | 2004-01-02 | — | — | EP | disclosed |
| EP-0878196-B1 | KAINIC ACID NEURONOTOXICITY INHIBITORS AND PYRIDOTHIAZINE DERIVATIVES | YAMANOUCHI PHARMA CO LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| EP-0882768-B1 | Method for producing of phthalocyanine compound | NIPPON CATALYTIC CHEM IND (JP) | 2001-12-19 | — | — | EP | disclosed |
| US-6133258-A | PYRIDOTHIAZINE DERIVATIVE; FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, MULTIPLE SCLEROSIS, PAIN, GLAUCOMA | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 2000-10-17 | — | — | US | disclosed |
| US-6034236-A | REACTING A PHTHALONITRILE WITH A METAL OXIDE IN PRESENCE OF A SULFONIC ACID CATALYST | NIPPON SHOKUBAI CO., LTD. (JP) | 2000-03-07 | — | — | US | disclosed |
| US-5998609-A | OPTICAL RECORDING MEDIA | NIPPON SHOKUBAI CO., LTD. (JP) | 1999-12-07 | — | — | US | disclosed |
| EP-0889097-A1 | PHTHALOCYANINE COMPOUNDS, PROCESS FOR PREPARING THE SAME, AND OPTICAL RECORDING MEDIUM MADE USING THE SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 1999-01-07 | — | — | EP | disclosed |
| EP-0882768-A2 | Method for producing of phthalocyanine compound | NIPPON SHOKUBAI CO., LTD. (JP) | 1998-12-09 | — | — | EP | disclosed |
| EP-0878196-A1 | KAINIC ACID NEURONOTOXICITY INHIBITORS AND PYRIDOTHIAZINE DERIVATIVES | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1998-11-18 | — | — | EP | disclosed |
| WO-1997032858-A1 | QUINOXALINE DERIVATIVES AS GLUTAMATE RECEPTOR ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-09-12 | — | — | WO | disclosed |